Skip to main content
. 2014 Oct 20;9(10):e110767. doi: 10.1371/journal.pone.0110767

Figure 1. Plasma levels of miR-15b, -27a, -223, -3145, -4638 and CA125 in validation phase.

Figure 1

Significant up-regulation of miR-15b, -27a, -223, and CA125 (A, B, C, and F) can be found in EEC patients, while there’s no statistically significant differences in the level of miR-3145 and -4638 (D and E) between the EEC and control. EEC: endometrial endometrioid adenocarcinoma.